drugset / Trial / NCT00986661
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
NaSingle-groupOpen-labelTreatment
Summary
This open-label study will evaluate the safety, tolerability, pharmacokinetics and effect on tumor growth following a single intralesional injection of PV-10 in subjects with either (a) hepatocellular carcinoma (HCC) that is not amenable to resection, transplant or other potentially curative therapy or (b) cancer metastatic to the liver.
Timeline
- Start
- 2009-10
- Primary completion
- 2022-12
- Completion
- 2023-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rose bengal disodium | Unknown | 0.25 ml | Other |
| Subject | rose bengal disodium | Unknown | 0.5 ml | Other |